BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 22412354)

  • 1. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
    Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
    PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
    Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users].
    Veljković M; Veljković S
    Med Pregl; 2010; 63(9-10):657-61. PubMed ID: 21446095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use?
    Khoo SK
    Med J Aust; 1986 Feb; 144(4):185-90. PubMed ID: 3511357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of oral contraceptives and risk of cancer, a cohort study].
    Kumle M; Alsaker E; Lund E
    Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1653-6. PubMed ID: 12821980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
    Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
    Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives.
    Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
    Aust N Z J Public Health; 2015 Oct; 39(5):441-5. PubMed ID: 26437729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and reproductive system cancer.
    Deligeoroglou E; Michailidis E; Creatsas G
    Ann N Y Acad Sci; 2003 Nov; 997():199-208. PubMed ID: 14644827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
    Gwinn ML
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
    Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V
    PLoS Med; 2023 Mar; 20(3):e1004188. PubMed ID: 36943819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study.
    La Vecchia C; Decarli A; Fasoli M; Franceschi S; Gentile A; Negri E; Parazzini F; Tognoni G
    Br J Cancer; 1986 Aug; 54(2):311-7. PubMed ID: 3741766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
    dos Santos Silva I; Swerdlow AJ
    Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
    Michels KA; Pfeiffer RM; Brinton LA; Trabert B
    JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
    Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
    Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does oral contraception cause cancer? (author's transl)].
    Kindermann G
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):213-9. PubMed ID: 1261787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
    Vessey M; Yeates D
    Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraception and cancer of the female reproductive system.
    Woods KL
    J Clin Hosp Pharm; 1985 Jun; 10(2):123-35. PubMed ID: 3894428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual, reproductive and contraceptive risk factors for carcinoma-in-situ of the uterine cervix in Sydney.
    Brock KE; Berry G; Brinton LA; Kerr C; MacLennan R; Mock PA; Shearman RP
    Med J Aust; 1989 Feb; 150(3):125-30. PubMed ID: 2716580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.